Mevalonate pathway: a review of clinical and therapeutical implications
- PMID: 17467679
- DOI: 10.1016/j.clinbiochem.2007.03.016
Mevalonate pathway: a review of clinical and therapeutical implications
Abstract
Mevalonate pathway is an important metabolic pathway which plays a key role in multiple cellular processes by synthesizing sterol isoprenoids, such as cholesterol, and non-sterol isoprenoids, such as dolichol, heme-A, isopentenyl tRNA and ubiquinone. While extensively studied in regard with cholesterol synthesis and its implications in cardiovascular diseases, in recent years the mevalonate pathway has become a challenging and, in the meantime, fascinating topic, when a large number of experimental and clinical studies suggested that inhibition of non-sterol isoprenoids might have valuable interest in human pathology. These molecules that are essential for cell growth and differentiation appear to be potential interesting therapeutic targets for many areas of ongoing research: oncology, autoimmune disorders, atherosclerosis, and Alzheimer disease. Also, considerable progress has been made in the past decade in understanding the pathophysiology of two auto-inflammatory disorders resulting from an inherited deficiency of mevalonate kinase, the first committed enzyme of the mevalonate pathway. Here we present a brief description of the biochemistry of the mevalonate pathway, together with a review of the current knowledge of the clinical and therapeutical implications of this fascinating and complex metabolic pathway.
Similar articles
-
Novel aspects of mevalonate pathway inhibitors as antitumor agents.Clin Cancer Res. 2012 Jul 1;18(13):3524-31. doi: 10.1158/1078-0432.CCR-12-0489. Epub 2012 Apr 23. Clin Cancer Res. 2012. PMID: 22529099 Review.
-
Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency.Pediatrics. 2007 Feb;119(2):e523-7. doi: 10.1542/peds.2006-2015. Epub 2007 Jan 29. Pediatrics. 2007. PMID: 17261617
-
Mevalonate kinase deficiency and autoinflammatory disorders.N Engl J Med. 2007 Jun 28;356(26):2671-3. doi: 10.1056/NEJMp078083. N Engl J Med. 2007. PMID: 17596600 No abstract available.
-
A role for geranylgeranylation in interleukin-1beta secretion.Arthritis Rheum. 2006 Nov;54(11):3690-5. doi: 10.1002/art.22194. Arthritis Rheum. 2006. PMID: 17075828
-
[Identification of the gene for hyper-IgD syndrome: a model of modern genetics].Ned Tijdschr Geneeskd. 2000 Apr 22;144(17):782-5. Ned Tijdschr Geneeskd. 2000. PMID: 10800545 Review. Dutch.
Cited by
-
Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.J Diabetes Res. 2015;2015:379287. doi: 10.1155/2015/379287. Epub 2015 Mar 30. J Diabetes Res. 2015. PMID: 25918730 Free PMC article.
-
Porokeratoses-A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants.Metabolites. 2023 Nov 26;13(12):1176. doi: 10.3390/metabo13121176. Metabolites. 2023. PMID: 38132857 Free PMC article. Review.
-
Plastid methylerythritol phosphate pathway participates in the hypersensitive response-related cell death in Nicotiana benthamiana.Front Plant Sci. 2022 Oct 26;13:1032682. doi: 10.3389/fpls.2022.1032682. eCollection 2022. Front Plant Sci. 2022. PMID: 36388595 Free PMC article.
-
Molecular docking and NMR binding studies to identify novel inhibitors of human phosphomevalonate kinase.Biochem Biophys Res Commun. 2013 Jan 4;430(1):313-9. doi: 10.1016/j.bbrc.2012.10.130. Epub 2012 Nov 10. Biochem Biophys Res Commun. 2013. PMID: 23146631 Free PMC article.
-
Enhancement of the anticancer effect of atorvastatin-loaded nanoemulsions by improving oral absorption via multivalent intestinal transporter-targeting lipids.Drug Deliv. 2022 Dec;29(1):3397-3413. doi: 10.1080/10717544.2022.2149896. Drug Deliv. 2022. PMID: 36419245 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous